| Characteristics | No. (%) of partners | |
| Cancer site |
| |
| Breast | 51 | (46.8) |
| Colorectal | 17 | (15.6) |
| Stomach | 10 | (9.2) |
| Other | 28 | (25.7) |
| Missing/Unknown | 3 | (2.8) |
| Cancer stage |
| |
| 0/I/II | 34 | (31.2) |
| III/IV | 50 | (45.9) |
| Missing/Unknown | 25 | (22.9) |
| Disease status |
| |
| First episode | 87 | (79.8) |
| Metastases/recurrence | 14 | (12.8) |
| Missing/Unknown | 8 | (7.3) |
| Years since diagnosis |
| |
| <1 | 56 | (51.4) |
| ≥1 and <5 | 38 | (34.9) |
| ≥5 | 13 | (11.9) |
| Missing | 2 | (1.8) |
| First treatment |
| |
| Surgery | 60 | (55.0) |
| Chemotherapy | 42 | (38.5) |
| Others | 6 | (5.5) |
| Missing/Unknown | 1 | (0.9) |
| Treatment Type |
| |
| Traditional chemotherapy | 54 | (49.5) |
| Targeted therapy | 22 | (20.2) |
| Traditional chemotherapy | 19 | (17.4) |
| Plus targeted therapy |
| |
| Missing/Unknown | 14 | (12.8) |
| Duration of current treatment |
|
|
| Median (IQR), month(s) | 3.0 | (0?9) |
| Missing/Unknown | 7 | (6.4) |
| Prior experience of chemotherapy |
| |
| Yes | 41 | (37.6) |
| No | 67 | (61.5) |
| Missing | 1 | (0.9) |